Iovance (IOVA) stock jumps again in premarket after 31% surge on earnings, sarcoma data
New York, February 25, 2026, 06:14 EST — Premarket Iovance Biotherapeutics jumped roughly 4% in premarket action Wednesday, following up on Tuesday’s 30.8% rally. Traders zeroed in on the most recent earnings release and a new analyst upgrade.